614
Views
90
CrossRef citations to date
0
Altmetric
Review

Type 2 diabetes mellitus as risk factor for colorectal cancer

&
Pages 84-98 | Received 31 Dec 2007, Accepted 22 Feb 2008, Published online: 10 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Doran Avivi, Menachem Moshkowitz, Elmar Detering & Nadir Arber. (2012) The role of low-dose aspirin in the prevention of colorectal cancer. Expert Opinion on Therapeutic Targets 16:sup1, pages S51-S62.
Read now
Jaladi Ashok Kumar, Ashok Kumar Tiwari, Amtul Zehra Ali, Kuncha Madhusudhana, Boreddy Srinivas Reddy, Sistala Ramakrishna & Bhimapaka China Raju. (2010) New antihyperglycemic, α-glucosidase inhibitory, and cytotoxic derivatives of benzimidazoles. Journal of Enzyme Inhibition and Medicinal Chemistry 25:1, pages 80-86.
Read now
Juergen Sandow. (2009) Growth effects of insulin and insulin analogues. Archives of Physiology and Biochemistry 115:2, pages 72-85.
Read now

Articles from other publishers (87)

Bayar Baban, Daniel Eklund, Kedeye Tuerxun, Muhammed Alshamari, Alessandro Laviano, Olle Ljungqvist & Eva Särndahl. (2023) Altered insulin sensitivity and immune function in patients with colorectal cancer. Clinical Nutrition ESPEN 58, pages 193-200.
Crossref
Maryam Mohamadi, Periklis Dousdampanis, Zahra Ahmadi, Soheila Pourmasumi, Monavare Naderi, Nahid Zainodini & Alireza Nazari. (2023) Nut consumption and urogenital and genital, gastrointestinal and women‐related cancers: Assessment and review. Chronic Diseases and Translational Medicine 9:4, pages 277-287.
Crossref
Zechen Liu & Mingyang Song. (2023) Prevalence of colorectal cancer and breast cancer screening according to history of diabetes in 2010–2019. Journal of Medical Screening 30:3, pages 156-158.
Crossref
Leyla de Avila, Linda Henry, James M. Paik, Naila Ijaz, Ali A. Weinstein & Zobair M. Younossi. (2023) Nonalcoholic Fatty Liver Disease Is Independently Associated With Higher All-Cause and Cause-Specific Mortality. Clinical Gastroenterology and Hepatology 21:10, pages 2588-2596.e3.
Crossref
Julianne G. Clina, R. Drew Sayer, Zhaoxing Pan, Caroline W. Cohen, Michael T. McDermott, Victoria A. Catenacci, Holly R. Wyatt & James O. Hill. (2023) High‐ and normal‐protein diets improve body composition and glucose control in adults with type 2 diabetes: a randomized trial. Obesity 31:8, pages 2021-2030.
Crossref
Martina Lepore Signorile, Valentina Grossi, Candida Fasano & Cristiano Simone. (2023) Colorectal Cancer Chemoprevention: A Dream Coming True?. International Journal of Molecular Sciences 24:8, pages 7597.
Crossref
Ping-Teng Chu, Tzu-Jung Chuang, Shu-Hung Huang, Tung-Ho Wu, Wei-Chun Huang & Jui-Ho Wang. (2023) The impact of metformin on survival in diabetes patients with operable colorectal cancer: A nationwide retrospective cohort study. Journal of International Medical Research 51:4, pages 030006052311680.
Crossref
Mafalda Miranda Baleiras, Tiago Dias Domingues, Eduardo Severino, Carolina Vasques, Maria Teresa Neves, André Ferreira, Leonor Vasconcelos de Matos, Filipa Ferreira, Helena Miranda & Ana Martins. (2023) Prognostic Impact of Type 2 Diabetes in Metastatic Colorectal Cancer. Cureus.
Crossref
Marcela Castro Ramos, Julio Augusto de Lima Passone, Ana Carolina de Freitas Lopes, Adriana Vaz Safatle-Ribeiro, Ulysses Ribeiro Júnior & Patrícia Coelho de Soárez. (2023) Economic evaluations of colorectal cancer screening: A systematic review and quality assessment. Clinics 78, pages 100203.
Crossref
Indu Sharma & Ranbir Chander Sobti. 2023. Handbook of Oncobiology: From Basic to Clinical Sciences. Handbook of Oncobiology: From Basic to Clinical Sciences 1 13 .
Phei Er Saw & Erwei Song. 2023. Tumor Ecosystem. Tumor Ecosystem 535 552 .
Huiying Li, Qianqian Yao, Chaonan Li, Linlin Fan, Haoming Wu, Nan Zheng & Jiaqi Wang. (2022) Lactoferrin Inhibits the Development of T2D-Induced Colon Tumors by Regulating the NT5DC3/PI3K/AKT/mTOR Signaling Pathway. Foods 11:24, pages 3956.
Crossref
Francesco Melia, Palita Udomjarumanee, Dmitry Zinovkin, Nahid Arghiani & Md Zahidul Islam Pranjol. (2022) Pro-tumorigenic role of type 2 diabetes-induced cellular senescence in colorectal cancer. Frontiers in Oncology 12.
Crossref
Shrimahitha Duraiyarasan, Mayowa Adefuye, Nisha Manjunatha, Vinutna Ganduri & Kruthiga Rajasekaran. (2022) Colon Cancer and Obesity: A Narrative Review. Cureus.
Crossref
Sung-Soo Kim & Hun-Sung Kim. (2022) The Impact of the Association between Cancer and Diabetes Mellitus on Mortality. Journal of Personalized Medicine 12:7, pages 1099.
Crossref
Deiana Roman, Sorin Saftescu, Bogdan Timar, Vlad Avram, Adina Braha, Șerban Negru, Andrei Bercea, Monica Serbulescu, Dorel Popovici & Romulus Timar. (2022) Diabetes Mellitus and Other Predictors for the Successful Treatment of Metastatic Colorectal Cancer: A Retrospective Study. Medicina 58:7, pages 872.
Crossref
Song-Seng Loke & Seng-Kee Chuah. (2022) Factors Associated with Colorectal Polyps in Middle-Aged and Elderly Populations. International Journal of Environmental Research and Public Health 19:12, pages 7543.
Crossref
Muhammad Tufail & Changxin Wu. (2022) Targeting the IGF-1R in prostate and colorectal cancer: reasons behind trial failure and future directions. Therapeutic Delivery 13:3, pages 167-186.
Crossref
Simone M. Lee, Vincent L. Versace & Kehinde Obamiro. (2022) Public Awareness of Bowel Cancer Risk Factors, Symptoms and Screening in Tasmania, Australia: A Cross-Sectional Study. International Journal of Environmental Research and Public Health 19:3, pages 1497.
Crossref
Giuseppe Ottone Cirulli, Alessandro Larcher, Francesco Montorsi & Alberto Martini. 2022. Men’s Health and Wellbeing. Men’s Health and Wellbeing 95 119 .
Feng Yang, Hong Liang, Raul J. Rosenthal & Steven D. Wexner. (2021) The significant interaction between age and diabetes mellitus for colorectal cancer: Evidence from NHANES data 1999–2016. Primary Care Diabetes 15:3, pages 518-521.
Crossref
Wedad Saeed Al-Qahtani, Ebtesam Al-Olayan, Fatimah Gh. Albani, Rania Saad Suliman, Nada Hamad Aljarba, E.M. Al-Humaidhi, Alanood S. Almurshedi, Dalia Mostafa Domiaty, Manal Abdullah Alduwish, Aljohara M. Al-Otaibi, Abdelbaset Mohamed Elasbali, Hussain Gadelkarim Ahmed & Bassam Ahmed Almutlaq. (2020) Utility of KRAS Gene and Clinicopathological Features in the Assessment of the Risk of Type 2 Diabetes in the Etiology of Colon Cancer. Global Medical Genetics 07:02, pages 035-040.
Crossref
Miren AlustizaEva Hernández-IllánMiriam JuárezMar Giner-CalabuigCristina MiraAlejandro Martínez-RocaLuis BujandaFrancisco Rodríguez-MorantaJoaquín CubiellaLuisa de-CastroJosé-Carlos Marín-GabrielAlberto Herreros-de-TejadaFernando Fernández-BañaresDavid Nicolás-PérezPaula GiménezClaudia Martínez-CardonaRubén FrancésOscar MurciaRodrigo Jover. (2020) Increased Th17-Related Cytokine Serum Levels in Patients With Multiple Polyps of Unexplained Origin. Clinical and Translational Gastroenterology 11:3, pages e00143.
Crossref
Nikola Besic & Milena Kerin Povsic. (2019) Long term survival in 200 patients with advanced stage of colorectal carcinoma and diabetes mellitus – a single institution experience. Radiology and Oncology 53:2, pages 238-244.
Crossref
Kuan-Fu Liao, Cheng-Li Lin & Shih-Wei Lai. (2019) Association between colorectal cancer and thiazolidinediones administration in a case-control study. BioMedicine 9:1, pages 4.
Crossref
I-Ping Yang, Zhi-Feng Miao, Ching-Wen Huang, Hsiang-Lin Tsai, Yung-Sung Yeh, Wei-Chih Su, Tsung-Kun Chang, Se-fen Chang & Jaw-Yuan Wang. (2019) High blood sugar levels but not diabetes mellitus significantly enhance oxaliplatin chemoresistance in patients with stage III colorectal cancer receiving adjuvant FOLFOX6 chemotherapy. Therapeutic Advances in Medical Oncology 11, pages 175883591986696.
Crossref
Amal Al OmariHadeel AbdelkhaleqMaysa Al-HussainiRim TurfaNour AwadManal M. HassanMahmoud A. AlfaqihChristopher R. Garrett. (2018) Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer. Journal of Global Oncology:4, pages 1-10.
Crossref
Wen‐Fang Peng, Feng Bai, Kan Shao, Li‐Sha Shen, Hui‐Hua Li & Shan Huang. (2018) The key genes underlying pathophysiology association between the type 2‐diabetic and colorectal cancer. Journal of Cellular Physiology 233:11, pages 8551-8557.
Crossref
Tina Fransgaard, Lau Caspar Thygesen & Ismail Gögenur. (2018) Association between metformin use after surgery for colorectal cancer and oncological outcomes: A nationwide register‐based study. International Journal of Cancer 143:1, pages 63-72.
Crossref
Yu-Tang Chang, Hsiang-Lin Tsai, Ya-Ting Kung, Yung-Sung Yeh, Ching-Wen Huang, Cheng-Jen Ma, Herng-Chia Chiu & Jaw-Yuan Wang. (2018) Dose-Dependent Relationship Between Metformin and Colorectal Cancer Occurrence Among Patients with Type 2 Diabetes—A Nationwide Cohort Study. Translational Oncology 11:2, pages 535-541.
Crossref
Devin Abrahami, Hui Yin, Oriana H. Y. Yu, Michael N. Pollak & Laurent Azoulay. (2018) Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 Diabetes. Epidemiology 29:2, pages 246-253.
Crossref
Roger C Zhu, Kirk Rattanakorn, Steven Pham, Divya Mallam, Thomas McIntyre, Moro O Salifu, Irini Youssef, Samy I McFarlane & Shivakumar Vignesh. (2017) Survival benefits in colorectal adenocarcinoma with the use of metformin among a black diabetic inner city population. Colorectal Cancer 6:1, pages 33-41.
Crossref
Kaori Fujiwara, Takuya Inoue, Yujiro Henmi, Yoshimasa Hirata, Yutaka Naka, Azusa Hara, Kazuki Kakimoto, Sadaharu Nouda, Toshihiko Okada, Ken Kawakami, Toshihisa Takeuchi & Kazuhide Higuchi. (2017) Sitagliptin, a dipeptidyl peptidase-4 inhibitor, suppresses CXCL5 and SDF-1 and does not accelerate intestinal neoplasia formation in ApcMin/+ mice fed a high-fat diet. Oncology Letters 14:4, pages 4355-4360.
Crossref
Marta Schirripa, Wu Zhang, Volker Heinemann, Shu Cao, Satoshi Okazaki, Dongyun Yang, Fotios Loupakis, Martin D. Berger, Yan Ning, Yuji Miyamoto, Mitsukuni Suenaga, Roel F. Gopez, Jordan D. West, Diana Hanna, Afsaneh Barzi, Alfredo Falcone, Sebastian Stintzing & Heinz‐Josef Lenz. (2017) Single nucleotide polymorphisms in the IGF‐IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE‐3 trial. International Journal of Cancer 141:2, pages 383-392.
Crossref
Ellena Badrick & Andrew G. Renehan. 2017. Textbook of Diabetes. Textbook of Diabetes 789 798 .
Yves Lecarpentier, Victor Claes, Alexandre Vallée & Jean-Louis Hébert. (2017) Interactions between PPAR Gamma and the Canonical Wnt/Beta-Catenin Pathway in Type 2 Diabetes and Colon Cancer. PPAR Research 2017, pages 1-9.
Crossref
Bo Young Oh, Yoon Ah Park, Jung Wook Huh, Yong Beom Cho, Seong Hyeon Yun, Woo Yong Lee, Hee Chul Park, Doo Ho Choi, Young Suk Park & Hee Cheol Kim. (2016) Metformin enhances the response to radiotherapy in diabetic patients with rectal cancer. Journal of Cancer Research and Clinical Oncology 142:6, pages 1377-1385.
Crossref
Rui Sun, Jian-Ping Liu, Chang Gao, Ying-Ying Xiong, Min Li, Ya-Ping Wang, Yan-Wei Su, Mei Lin, An-Li Jiang, Ling-Fan Xiong, Yan Xie & Jue-Ping Feng. (2016) Two variants on T2DM susceptible gene HHEX are associated with CRC risk in a Chinese population. Oncotarget 7:20, pages 29770-29779.
Crossref
Su Luo, Jie-Yao Li, Li-Na Zhao, Tao Yu, Wa Zhong, Zhong-Sheng Xia, Ti-Dong Shan, Hui Ouyang, Hong-Sheng Yang & Qi-Kui Chen. (2016) Diabetes mellitus increases the risk of colorectal neoplasia: An updated meta-analysis. Clinics and Research in Hepatology and Gastroenterology 40:1, pages 110-123.
Crossref
Carmen Olmos, Isidre Vilacosta, Cristina Sarriá, Javier López, Carlos Ferrera, Carmen Sáez, David Vivas, Miguel Hernández, Cristina Sánchez-Enrique, Pablo Elpidio García-Granja, Elisa Pérez-Cecilia, Luis Maroto & José Alberto San Román. (2016) Streptococcus bovis endocarditis: Update from a multicenter registry. American Heart Journal 171:1, pages 7-13.
Crossref
So Yeon Kong, Masayoshi Takeuchi, Hideyuki Hyogo, Gail McKeown-Eyssen, Sho-ichi Yamagishi, Kazuaki Chayama, Peter J. O'Brien, Pietro Ferrari, Kim Overvad, Anja Olsen, Anne Tjønneland, Marie-Christine Boutron-Ruault, Nadia Bastide, Franck Carbonnel, Tilman Kühn, Rudolf Kaaks, Heiner Boeing, Krasimira Aleksandrova, Antonia Trichopoulou, Pagona Lagiou, Effie Vasilopoulou, Giovanna Masala, Valeria Pala, Maria Santucci De Magistris, Rosario Tumino, Alessio Naccarati, H.B. Bueno-de-Mesquita, Petra H. Peeters, Elisabete Weiderpass, J. Ramón Quirós, Paula Jakszyn, María-José Sánchez, Miren Dorronsoro, Diana Gavrila, Eva Ardanaz, Martin Rutegård, Hanna Nyström, Nicholas J. Wareham, Kay-Tee Khaw, Kathryn E. Bradbury, Isabelle Romieu, Heinz Freisling, Faidra Stavropoulou, Marc J. Gunter, Amanda J. Cross, Elio Riboli, Mazda Jenab & W. Robert Bruce. (2015) The Association between Glyceraldehyde-Derived Advanced Glycation End-Products and Colorectal Cancer Risk. Cancer Epidemiology, Biomarkers & Prevention 24:12, pages 1855-1863.
Crossref
Naoki Yorifuji, Takuya Inoue, Munetaka Iguchi, Kaori Fujiwara, Kazuki Kakimoto, Sadaharu Nouda, Toshihiko Okada, Ken Kawakami, Yosuke Abe, Toshihisa Takeuchi & Kazuhide Higuchi. (2015) The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type�2 diabetic mice. Oncology Reports.
Crossref
Yao-Hsien Tseng, Yu-Tse Tsan, Wei-Cheng Chan, Wayne Huey-Herng Sheu & Pau-Chung Chen. (2015) Use of an α-Glucosidase Inhibitor and the Risk of Colorectal Cancer in Patients With Diabetes: A Nationwide, Population-Based Cohort Study. Diabetes Care 38:11, pages 2068-2074.
Crossref
Yanglei Jia, Zengyi Ma, Xiaofei Liu, Wenjing Zhou, Shan He, Xia Xu, Guijie Ren, Gang Xu & Keli Tian. (2015) Metformin prevents DMH ‐induced colorectal cancer in diabetic rats by reversing the warburg effect . Cancer Medicine 4:11, pages 1730-1741.
Crossref
Paolo Giovanni Vigneri, Elena Tirrò, Maria Stella Pennisi, Michele Massimino, Stefania Stella, Chiara Romano & Livia Manzella. (2015) The Insulin/IGF System in Colorectal Cancer Development and Resistance to Therapy. Frontiers in Oncology 5.
Crossref
Xian-Yang Zhong, Tao Yu, Wa Zhong, Jie-Yao Li, Zhong-Sheng Xia, Yu-Hong Yuan, Zhong Yu & Qi-Kui Chen. (2015) Lgr5 positive stem cells sorted from small intestines of diabetic mice differentiate into higher proportion of absorptive cells and Paneth cells in vitro . Development, Growth & Differentiation 57:6, pages 453-465.
Crossref
C. C. Lin, M. S. Lai & W. Y. Shau. (2015) Can aspirin reduce the risk of colorectal cancer in people with diabetes? A population-based cohort study. Diabetic Medicine 32:3, pages 324-331.
Crossref
G.H. Lee, G. Malietzis, A. Askari, D. Bernardo, H.O. Al-Hassi & S.K. Clark. (2015) Is right-sided colon cancer different to left-sided colorectal cancer? – A systematic review. European Journal of Surgical Oncology (EJSO) 41:3, pages 300-308.
Crossref
Claudia Abbruzzese, Maria Grazia Diodoro, Isabella Sperduti, Anna Maria Mileo, Giada Pattaro, Laura De Salvo, Maurizio Cosimelli, Nicola Perrotti & Marco G. Paggi. (2015) Detection of Phosphorylated Insulin Receptor in Colorectal Adenoma and Adenocarcinoma: Implications for Prognosis and Clinical Outcome. Journal of Cellular Physiology 230:3, pages 562-567.
Crossref
Yaser Khaje Bishak, Laleh Payahoo, Alireza Osatdrahimi & Alireza Nourazarian. (2015) Mechanisms of Cadmium Carcinogenicity in the Gastrointestinal Tract. Asian Pacific Journal of Cancer Prevention 16:1, pages 9-21.
Crossref
Amanda Kimura, Mo-Kyung Sin, Clarence Spigner, Anh Tran & Shin-Ping Tu. (2014) Barriers and Facilitators to Colorectal Cancer Screening in Vietnamese Americans: A Qualitative Analysis. Journal of Cancer Education 29:4, pages 728-734.
Crossref
Yanglei Jia, Gang Xu, Wenjing Zhou, Zhenzheng Wang, Linlin Meng, Songnan Zhou, Xia Xu, Huiqing Yuan & Keli Tian. (2014) Diabetes Promotes DMH-Induced Colorectal Cancer by Increasing the Activity of Glycolytic Enzymes in Rats. PLoS ONE 9:10, pages e110455.
Crossref
Rui Liu, Li-Ling Hu, Ao Sun, Ya-Jing Cao, Tao Tang, Xi-Peng Zhang & Qing-Huai Zhang. (2014) mRNA Expression of IGF-1 and IGF-1R in Patients with Colorectal Adenocarcinoma and Type 2 Diabetes. Archives of Medical Research 45:4, pages 318-324.
Crossref
J Luo, H-C Lin, K He & M Hendryx. (2014) Diabetes and prognosis in older persons with colorectal cancer. British Journal of Cancer 110:7, pages 1847-1854.
Crossref
Yang ChenRong Xu. (2014) Mining Cancer-Specific Disease Comorbidities from a Large Observational Health Database. Cancer Informatics 13s1, pages CIN.S13893.
Crossref
Katherine T. Mills, Charles F. Bellows, Aaron E. Hoffman, Tanika N. Kelly & Giuseppe Gagliardi. (2013) Diabetes Mellitus and Colorectal Cancer Prognosis. Diseases of the Colon & Rectum 56:11, pages 1304-1319.
Crossref
Mehulkumar K. Kanadiya, Tushar D. Gohel, Madhusudhan R. Sanaka, Prashanthi N. Thota & Jay H. ShubrookJr.Jr.. (2013) Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy. Journal of Diabetes and its Complications 27:5, pages 463-466.
Crossref
Paweł Piątkiewicz, Tomasz Miłek, Małgorzata Bernat-Karpińska, Monika Ohams, Anna Czech & Piotr Ciostek. (2013) The Dysfunction of NK Cells in Patients with Type 2 Diabetes and Colon Cancer. Archivum Immunologiae et Therapiae Experimentalis 61:3, pages 245-253.
Crossref
Lei WuChao YuHan JiangJun TangHe-lang HuangJing GaoXin Zhang. (2013) Diabetes Mellitus and the Occurrence of Colorectal Cancer: An Updated Meta-Analysis of Cohort Studies. Diabetes Technology & Therapeutics 15:5, pages 419-427.
Crossref
Jen-Yu Wang, Ting-Ting Chao, Chih-Cheng Lai, Cheng-Yi Wang, Vin-Cent Wu, So-Mon Wang, Hen-I Lin, Sai-Hung Tang & Hui-Wen Lin. (2013) Risk of Colorectal Cancer in Type 2 Diabetic Patients: A Population-based Cohort Study. Japanese Journal of Clinical Oncology 43:3, pages 258-263.
Crossref
Juhua Luo, Rowan Chlebowski, Simin Liu, Katherine A. McGlynn, Niyati Parekh, Donna L. White & Karen L. Margolis. (2012) Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women. Cancer Causes & Control 24:3, pages 577-585.
Crossref
Khokan C. Sikdar, Stephanie J. Walsh, Madonna Roche, Ying Jiang, Ania Syrowatka & Kayla D. Collins. (2013) Diabetes and Sex-specific Colorectal Cancer Risks in Newfoundland and Labrador: A Population-based Retrospective Cohort Study. Canadian Journal of Public Health 104:2, pages e101-e107.
Crossref
Justin Y. Jeon, Duck Hyoun Jeong, Min Geun Park, Ji-Won Lee, Sang Hui Chu, Ji-Hye Park, Mi Kyung Lee, Kaori Sato, Jennifer A. Ligibel, Jeffrey A. Meyerhardt & Nam Kyu Kim. (2013) Impact of Diabetes on Oncologic Outcome of Colorectal Cancer Patients: Colon vs. Rectal Cancer. PLoS ONE 8:2, pages e55196.
Crossref
Dianna J Magliano, Wendy A Davis, Jonathan E Shaw, David G Bruce & Timothy M E Davis. (2012) Incidence and predictors of all-cause and site-specific cancer in type 2 diabetes: the Fremantle Diabetes Study. European Journal of Endocrinology 167:4, pages 589-599.
Crossref
Chung-Jyi Tsai & Edward L. Giovannucci. (2012) Hyperinsulinemia, Insulin Resistance, Vitamin D, and Colorectal Cancer Among Whites and African Americans. Digestive Diseases and Sciences 57:10, pages 2497-2503.
Crossref
Sashwati Roy, Debasis Bagchi & Siba RaychaudhuriEdite de Lemos & Flávio Reis. 2012. Chronic Inflammation. Chronic Inflammation 287 304 .
R. Göke. (2012) Krebsvorbeugung und -vorsorge bei DiabetespatientenCancer prevention and prophylaxis in diabetes patients. Der Diabetologe 8:6, pages 479-485.
Crossref
Jin Ha Lee, Tae Il Kim, Soung Min Jeon, Sung Pil Hong, Jae Hee Cheon & Won Ho Kim. (2012) The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus. International Journal of Cancer 131:3, pages 752-759.
Crossref
K. Hata, M. Kubota, M. Shimizu, H. Moriwaki, T. Kuno, T. Tanaka, A. Hara & Y. Hirose. (2012) Monosodium glutamate-induced diabetic mice are susceptible to azoxymethane-induced colon tumorigenesis. Carcinogenesis 33:3, pages 702-707.
Crossref
Stéphanie Olivier-Van Stichelen, Céline Guinez, Anne-Marie Mir, Yobana Perez-Cervera, Chunming Liu, Jean-Claude Michalski & Tony Lefebvre. (2012) The hexosamine biosynthetic pathway and O -GlcNAcylation drive the expression of β-catenin and cell proliferation . American Journal of Physiology-Endocrinology and Metabolism 302:4, pages E417-E424.
Crossref
Hua-Fen Chen, Peter Chen, Ying-Hwa Su, Hui-Fang Su & Chung-Yi Li. (2012) Age- and Sex-Specific Risks of Colorectal Cancers in Diabetic Patients. The Tohoku Journal of Experimental Medicine 226:4, pages 259-265.
Crossref
Michael Erbach, Hellmut Mehnert & Oliver Schnell. (2012) Diabetes and the risk for colorectal cancer. Journal of Diabetes and its Complications 26:1, pages 50-55.
Crossref
Kazuya Hata, Masaya Kubota, Masahito Shimizu, Hisataka Moriwaki, Toshiya Kuno, Takuji Tanaka, Akira Hara & Yoshinobu Hirose. (2011) C57BL/KsJ-db/db-ApcMin/+ Mice Exhibit an Increased Incidence of Intestinal Neoplasms. International Journal of Molecular Sciences 12:11, pages 8133-8145.
Crossref
Sung-Jin Kim & Os Sethu Raman. (2011) Syndecan as a Messenger to Link Diabetes and Cancer. Biomolecules and Therapeutics 19:3, pages 267-273.
Crossref
Michael S. Simon, Cynthia A. Thomson, Erin Pettijohn, Ikuko Kato, Rebecca J. Rodabough, Dorothy Lane, F. Allan Hubbell, Mary Jo O'Sullivan, Lucille Adams-Campbell, Charles P. Mouton, Judith Abrams & Rowan T. Chlebowski. (2011) Racial Differences in Colorectal Cancer Incidence and Mortality in the Women's Health Initiative. Cancer Epidemiology, Biomarkers & Prevention 20:7, pages 1368-1378.
Crossref
Bente K. Pedersen. (2011) Exercise-induced myokines and their role in chronic diseases. Brain, Behavior, and Immunity 25:5, pages 811-816.
Crossref
C. Jaursch-Hancke. (2011) Gastrointestinale Probleme bei DiabetesDiabetes and gastrointestinal symptoms. Der Gastroenterologe 6:4, pages 300-306.
Crossref
Joseph C. Anderson. 2011. Colorectal Cancer Screening. Colorectal Cancer Screening 7 23 .
Jutta M. Nagel, Jürgen Staffa, Ingrid Renner-Müller, David Horst, Michael Vogeser, Markus Langkamp, Andreas Hoeflich, Burkhard Göke, Frank T. Kolligs & Christos S. Mantzoros. (2010) Insulin Glargine and NPH Insulin Increase to a Similar Degree Epithelial Cell Proliferation and Aberrant Crypt Foci Formation in Colons of Diabetic Mice. Hormones and Cancer 1:6, pages 320-330.
Crossref
E. Yehezkel, D. Weinstein, M. Simon, R. Sarfstein, Z. Laron & H. Werner. (2010) Long-acting insulin analogues elicit atypical signalling events mediated by the insulin receptor and insulin-like growth factor-I receptor. Diabetologia 53:12, pages 2667-2675.
Crossref
Bente K. Pedersen. (2009) The diseasome of physical inactivity - and the role of myokines in muscle-fat cross talk. The Journal of Physiology 587:23, pages 5559-5568.
Crossref
Ming Zhao, Zhu-li Wan, Linda Whittaker, Bin Xu, Nelson B. Phillips, Panayotis G. Katsoyannis, Faramarz Ismail-Beigi, Jonathan Whittaker & Michael A. Weiss. (2009) Design of an Insulin Analog with Enhanced Receptor Binding Selectivity. Journal of Biological Chemistry 284:46, pages 32178-32187.
Crossref
Pooja PothiwalaM.D.M.D., Sushil K. JainPh.D.Ph.D. & Subhashini YaturuM.D.M.D.. (2009) Metabolic Syndrome and Cancer. Metabolic Syndrome and Related Disorders 7:4, pages 279-288.
Crossref
Masahito Shimizu, Yohei Shirakami, Junpei Iwasa, Makoto Shiraki, Yoichi Yasuda, Kazuya Hata, Yoshinobu Hirose, Hisashi Tsurumi, Takuji Tanaka & Hisataka Moriwaki. (2009) Supplementation with Branched-chain Amino Acids Inhibits Azoxymethane-induced Colonic Preneoplastic Lesions in Male C57BL/KsJ- db/db Mice . Clinical Cancer Research 15:9, pages 3068-3075.
Crossref
Sara Padidar, Andrew J. Farquharson, Garry J. Rucklidge & Janice E. Drew. (2008) Influence of increased adiposity on mitochondrial-associated proteins of the rat colon: A proteomic and transcriptomic analysis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1782:9, pages 532-541.
Crossref
Andrew G. Renehan & Bernadette M. Brennan. (2008) Acromegaly, growth hormone and cancer risk. Best Practice & Research Clinical Endocrinology & Metabolism 22:4, pages 639-657.
Crossref
Mutaz Arafat Altamimi. (2013) The Relationship between Type 2 Diabetes and Cancer: An Integrative Review. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.